Literature DB >> 22555654

Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2).

Claudio Ruffmann1, Michela Zini, Stefano Goldwurm, Manuela Bramerio, Sonia Spinello, Damiana Rusconi, Marcello Gambacorta, Fabrizio Tagliavini, Gianni Pezzoli, Giorgio Giaccone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555654     DOI: 10.1007/s00401-012-0991-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  7 in total

1.  The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.

Authors:  Madeleine E Sharp; Elise Caccappolo; Helen Mejia-Santana; Ming-X Tang; Llency Rosado; Martha Orbe Reilly; Diana Ruiz; Elan D Louis; Cynthia Comella; Martha Nance; Susan Bressman; William K Scott; Caroline Tanner; Cheryl Waters; Stanley Fahn; Lucien Cote; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald Pfeiffer; Haydeh Payami; Eric Molho; Stuart A Factor; John Nutt; Carmen Serrano; Maritza Arroyo; Michael W Pauciulo; William C Nichols; Lorraine N Clark; Roy N Alcalay; Karen S Marder
Journal:  Mov Disord       Date:  2014-11-12       Impact factor: 10.338

Review 2.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.

Authors:  Sangwoo Ham; Seung Pil Yun; Hyojung Kim; Donghoon Kim; Bo Am Seo; Heejeong Kim; Jeong-Yong Shin; Mohamad Aasif Dar; Gum Hwa Lee; Yun Il Lee; Doyeun Kim; Sunghoon Kim; Hee-Seok Kweon; Joo-Ho Shin; Han Seok Ko; Yunjong Lee
Journal:  Sci Transl Med       Date:  2020-11-11       Impact factor: 17.956

5.  Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.

Authors:  Madeleine E Sharp; Karen S Marder; Lucien Côté; Lorraine N Clark; William C Nichols; Jean-Paul Vonsattel; Roy N Alcalay
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

6.  A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in Parkin.

Authors:  Krisztina Kunszt Johansen; Sverre Helge Torp; Matthew J Farrer; Emil K Gustavsson; Jan O Aasly
Journal:  Case Rep Neurol Med       Date:  2018-06-28

Review 7.  Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease.

Authors:  Daniel Aghaie Madsen; Sissel Ida Schmidt; Morten Blaabjerg; Morten Meyer
Journal:  Cells       Date:  2021-01-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.